The table below shows CervoMed Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$0.00
$322.57K
$1.76M
$1.92M
$1.94M
$3.29M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$5.14M
$6.04M
$5.11M
$4.84M
$5.13M
$3.77M
SG&A
CRVO annual revenue (10-K history)
CervoMed Inc. reported annual revenue of $4.01M for fiscal year 2025. That is down 58.9% from $9.74M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $40.19K (FY 2010) to $4.01M. Figures come from the company's audited annual reports as filed with the SEC.